- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01420640
Tai Chi and Aerobic Exercise for Fibromyalgia (FMEx) (FMEx)
Tai Chi and Aerobic Exercise for Fibromyalgia
Study Overview
Status
Conditions
Detailed Description
Fibromyalgia (FM) is a chronic musculoskeletal pain syndrome that causes substantial physical and psychological impairment and costs over $25 billion annually. Current pharmacological therapies may be expensive, cause serious adverse effects, and fail to effectively improve pain and function. Finding new and effective non-pharmacological treatments for FM patients is urgently needed.
We propose to conduct the first comparative effectiveness trial of Tai Chi vs. aerobic exercise (a recommended component of the current standard of care) and to evaluate effectiveness under different Tai Chi dosing schedules in a large FM population. We aim to (1) demonstrate that, compared to aerobic exercise, Tai Chi is a more effective intervention for managing the pain and improving the functional limitations that impact quality of life for FM patients, and 2) determine the optimal frequency and duration of a supervised Tai Chi intervention in relation to short and long-term effectiveness. To achieve this goal, we will conduct a single-blind, randomized controlled trial of Tai Chi vs. aerobic exercise in 216 patients who meet the American College of Rheumatology criteria for FM. Patients will be randomized to one of four Tai Chi intervention groups: 12 or 24 weeks of supervised Tai Chi given once or twice per week, or a supervised aerobic exercise control: 2x/week for 24 weeks. All groups will have a 52-week follow-up. The primary outcome will be the FM Impact Questionnaire total score at 24 weeks. Secondary outcomes include the measures of widespread pain, functional performance, psychological functioning, self-efficacy, sleep quality, and quality of life at 12, 24, and 52 weeks.
Successful completion of the proposed study will determine the ideal regimen of Tai Chi and demonstrate that Tai Chi can be a simple, effective, and durable treatment for this therapeutically challenging disorder.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- Tufts Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 21 years or older.
- Fulfills the American College of Rheumatology (ACR) 1990 classification criteria for FM: (1) a history of widespread musculoskeletal pain on the right and left sides of the body as well as above and below the waist for a minimum duration of 3 months, and (2) pain in 11 or more of 18 specific tender points with moderate or greater tenderness reported upon digital palpation.27
- Fulfills the ACR 2010 diagnostic criteria for FM: (WPI ≥7 AND SS ≥5) OR (WPI 3-6 AND SS ≥9) and does not have a disorder that would otherwise explain the pain28
- Willing to complete the 12-week or 24-week study, including once or twice-a-week exercise sessions.
- Willing to abstain from Tai Chi or other new formalized exercise programs until completion of the study if randomized to the Aerobic Exercise.
- Willing to abstain from Aerobic Exercise or other new formalized exercise programs until completion of the study if randomized to Tai Chi
Exclusion Criteria:
- Prior experience with Tai Chi or other similar types of Complementary and Alternative Medicine in the past 1 year such as Qi gong and yoga since these share some of the principles of Tai Chi.
- Dementia, neurological disease, cancer, cardiovascular disease, pulmonary disease, metabolic disease, renal disease, liver disease, or other serious medical conditions limiting ability to participate in the Tai Chi or Aerobic Exercise programs, as determined by the study physicians.
- Any other diagnosed medical condition known to contribute to FM symptomatology that is not under adequate control for the study period such as thyroid disease, inflammatory arthritis, systemic lupus erythematosus, rheumatoid arthritis, myositis, vasculitis or Sjogren's syndrome.
- Inability to pass the Mini-Mental Status examination (with a score below 24) 29
- Enrollment in any other clinical trial within the last 30 days
- Plan to permanently relocate from the region during the trial period
- Positive urine pregnancy test at baseline or planning pregnancy within the study period
- Not English-Speaking: English is the only language to be used during the exercise training program. Our self-reported outcome measures are obtained from validated English-version questionnaires. In addition, using other languages would likely require separate classes, recruitment and instructors which are beyond our current study scope
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Tai Chi
|
12 weeks of supervised Tai Chi classes, 1x/week
12 weeks of supervised Tai Chi classes, 2x/week
24 weeks of supervised Tai Chi classes, 1x/week
24 weeks of supervised Tai Chi classes, 2x/week
|
|
Active Comparator: Aerobic Exercise Training
|
24 weeks of supervised aerobic exercise training, 2x/week
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Fibromyalgia Impact Questionnaire (FIQ) from baseline to 24 weeks
Time Frame: Week 0, Week 24
|
Overall severity of FM, intensity of pain, physical function, fatigue, morning tiredness, depression, anxiety, job difficulty, and overall well-being
|
Week 0, Week 24
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Fibromyalgia Impact Questionnaire at follow-up
Time Frame: Week 0, Week 12, Week 52
|
Overall severity of FM, intensity of pain, physical function, fatigue, morning tiredness, depression, anxiety, job difficulty, and overall well-being
|
Week 0, Week 12, Week 52
|
|
FM Symptom Severity Scale
Time Frame: Week 0, Week 12, Week 24, Week 52
|
FM symptoms
|
Week 0, Week 12, Week 24, Week 52
|
|
Body Mass Index (BMI)
Time Frame: Week 0, Week 12, Week 24, Week 52
|
General health
|
Week 0, Week 12, Week 24, Week 52
|
|
Medical Outcome Study Short Form 36 (SF-36)
Time Frame: Week 0, Week 12, Week 24, Week 52
|
General health/functional status
|
Week 0, Week 12, Week 24, Week 52
|
|
Patient Global Assessment
Time Frame: Week 0, Week 12, Week 24, Week 52
|
General health/functional status
|
Week 0, Week 12, Week 24, Week 52
|
|
The Beck Depression Inventory II
Time Frame: Week 0, Week 12, Week 24, Week 52
|
Depression
|
Week 0, Week 12, Week 24, Week 52
|
|
The Chronic Pain Self-Efficacy Scale (CPSS)
Time Frame: Week 0, Week 12, Week 24, Week 52
|
Chronic pain
|
Week 0, Week 12, Week 24, Week 52
|
|
The Pittsburg Sleep Quality Index (PSQI)
Time Frame: Week 0, Week 12, Week 24, Week 52
|
Sleep quality
|
Week 0, Week 12, Week 24, Week 52
|
|
The Sleep Quality Numeric Rating Scale (NRS)
Time Frame: Week 0, Week 12, Week 24, Week 52
|
Sleep quality
|
Week 0, Week 12, Week 24, Week 52
|
|
6-Minute Walk
Time Frame: Week 0, Week 12, Week 24, Week 52
|
Walking ability and Endurance
|
Week 0, Week 12, Week 24, Week 52
|
|
The Chair Stand Test
Time Frame: Week 0, Week 12, Week 24, Week 52
|
Physical functioning
|
Week 0, Week 12, Week 24, Week 52
|
|
The brief Outcome Expectation Scale (OES)
Time Frame: Week 0, Week 12, Week 24, Week 52
|
Outcome expectations
|
Week 0, Week 12, Week 24, Week 52
|
|
Health Assessment Questionnaire (HAQ)
Time Frame: Week 0, Week 12, Week 24, Week 52
|
Healthcare cost and utilization
|
Week 0, Week 12, Week 24, Week 52
|
|
PROMIS Health Assessment Questionnaire (HAQ)
Time Frame: Week 0, Week 12, Week 24, Week 52
|
Health status
|
Week 0, Week 12, Week 24, Week 52
|
|
Muscle Strength/Power and Balance
Time Frame: Week 0, Week 12, Week 24, Week 52
|
Physical functioning as assessed by muscle strength and power, and balance
|
Week 0, Week 12, Week 24, Week 52
|
|
CHAMPS Activities Questionnaire for Older Adults
Time Frame: Week 0, Week 12, Week 24, Week 52
|
Activity levels
|
Week 0, Week 12, Week 24, Week 52
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Wang C, Collet JP, Lau J. The effect of Tai Chi on health outcomes in patients with chronic conditions: a systematic review. Arch Intern Med. 2004 Mar 8;164(5):493-501. doi: 10.1001/archinte.164.5.493.
- Wang C, Roubenoff R, Lau J, Kalish R, Schmid CH, Tighiouart H, Rones R, Hibberd PL. Effect of Tai Chi in adults with rheumatoid arthritis. Rheumatology (Oxford). 2005 May;44(5):685-7. doi: 10.1093/rheumatology/keh572. Epub 2005 Mar 1. No abstract available.
- Wang C, Schmid CH, Rones R, Kalish R, Yinh J, Goldenberg DL, Lee Y, McAlindon T. A randomized trial of tai chi for fibromyalgia. N Engl J Med. 2010 Aug 19;363(8):743-54. doi: 10.1056/NEJMoa0912611.
- Wang C, Schmid CH, Hibberd PL, Kalish R, Roubenoff R, Rones R, McAlindon T. Tai Chi is effective in treating knee osteoarthritis: a randomized controlled trial. Arthritis Rheum. 2009 Nov 15;61(11):1545-53. doi: 10.1002/art.24832.
- Park M, Bannuru RR, Price LL, Harvey WF, Driban JB, Wang C. Effective recruitment strategies in an exercise trial for patients with fibromyalgia. Trials. 2021 Aug 21;22(1):557. doi: 10.1186/s13063-021-05502-3.
- Wang C, Schmid CH, Fielding RA, Harvey WF, Reid KF, Price LL, Driban JB, Kalish R, Rones R, McAlindon T. Effect of tai chi versus aerobic exercise for fibromyalgia: comparative effectiveness randomized controlled trial. BMJ. 2018 Mar 21;360:k851. doi: 10.1136/bmj.k851.
- Wang C, McAlindon T, Fielding RA, Harvey WF, Driban JB, Price LL, Kalish R, Schmid A, Scott TM, Schmid CH. A novel comparative effectiveness study of Tai Chi versus aerobic exercise for fibromyalgia: study protocol for a randomized controlled trial. Trials. 2015 Jan 30;16:34. doi: 10.1186/s13063-015-0548-x.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R01AT006367-01A1 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
Ionclinics & Deionic SLHospital Clínico Universitario de ValenciaNot yet recruitingFibromyalgia (FM)Spain
-
Ain Shams UniversityRecruiting
-
Selcuk UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...CompletedFibromyalgia (FM)Spain
-
Istanbul Gelisim UniversityBahçeşehir UniversityCompleted
-
Gazi UniversityCompletedFibromyalgia SyndromeTurkey (Türkiye)
-
University of UtahRecruitingFibromyalgia (FM)United States
-
María Catalina Osuna PérezActive, not recruitingFibromyalgia SyndromeSpain
-
Istanbul UniversityCompletedFibromyalgia | Fibromyalgia Syndrome | Fibromyalgia (FM)Turkey (Türkiye)
Clinical Trials on Lower frequency, shorter period of Tai Chi
-
Lidian ChenPeking University Third HospitalNot yet recruiting
-
Dominque BullensJessa Hospital; Imelda Hospital, Bonheiden; AZ Sint-Jan AV; Algemeen Ziekenhuis...Active, not recruiting
-
University of North Carolina, Chapel HillArthritis FoundationCompleted
-
University of California, San FranciscoUniversity of California, Los Angeles; United States Department of Defense; San... and other collaboratorsCompletedMild Cognitive Impairment | Subjective Memory DeclineUnited States
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
The First Affiliated Hospital with Nanjing Medical...SIR RUNRUN HospitalRecruiting
-
University Hospital, GhentCompletedFluid Overload | Venous Insufficiency of Leg | NocturiaBelgium
-
Aswan University HospitalCompletedCesarean Section ComplicationsEgypt
-
University of California, DavisNational Institute on Aging (NIA); Alzheimer's AssociationCompletedCognitive Impairment | Alzheimer's Disease (Incl Subtypes)United States
-
Indiana UniversityNational Institute on Aging (NIA); Alzheimer's Therapeutic Research Institute; Alzheimer's Association and other collaboratorsRecruitingAlzheimer Disease, Early OnsetUnited States